FOR PARTICIPANTS: Important information about ASPREE-XT and COVID-19 In light of easing of restrictions in some locations, we are pleased to be able to resume face-to-face annual study visits in many parts of south eastern Australia. In-person study visits will be subject to advice from the Department of Health in your state or territory…
Details
Statins may prevent heart attacks and strokes but may not prolong life free of disability A new observational study shows the first-line cholesterol-lowering drugs known as statins are associated with fewer heart attacks and strokes, but not associated with a prolonged life free of physical disability or dementia in healthy older people. The study…
Details
ASPREE’s sub-study, ASPREE-D (depression) publishes findings on effect of daily low dose aspirin on prevention of depression. PRESS RELEASE: 4th June 2020 – Taking low dose aspirin daily does not prevent depression in healthy older adults, according to collaborative researchers at the Institute for Mental and Physical Health and Clinical Translation (IMPACT) and the ASPREE (ASPirin in Reducing Events in the Elderly) Clinical Trial.
Details
FOR PARTICIPANTS: Important information about ASPREE-XT and the Coronavirus (COVID-19) In light of public health recommendations to help slow the spread of Coronavirus (COVID-19) in the community, ASPREE-XT will be temporarily replacing annual face-to-face study visits with a phone call. This decision, which took effect as of Monday 23rd March 2020, will continue until further notice.…
Details© 2019 All Rights Reserved. • Monash University, Department of Epidemiology and Preventive Medicine | Disclaimer & Privacy